Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,159.7
0.9 (0.03%)

 

  • STI Straits Times Index
    3,159.7
    0.9 (0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,597.4
    1.1 (0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,435.7
    -33.3 (-0.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,006.4
    7.2 (0.24%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,079.1
    34.6 (0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,231.5
    -13.0 (-0.21%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,091.5
    11.2 (0.54%)
    Index delayed 20 minutes
  • XAO XAO
    6,839.0
    13.8 (0.20%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 900.5M
  • Value: 1,592.9M
  • Rise: 124
  • Fall: 142
  • Unch: 570

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Keppel DC Reit2.110+0.040
YZJ Shipbldg SGD1.000-0.050
HPH Trust USD0.168-0.006
ThaiBev0.895-0.010
Frasers Cpt Tr2.750+0.020
TEE Intl0.043-0.004
Mapletree Com Tr2.290+0.020
Rex Intl0.084-0.001
Mapletree Log Tr1.630+0.020
Golden Agri-Res0.245-

World Indices

World Indices
Name Last Change
Nasdaq 8,182.9 +5.5
HSI 26,435.7 -33.3
HSCEI 10,375.6 -9.7
Jakarta 6,231.5 -13.0
Nikkei 225 22,079.1 +34.6
SSE Comp 3,006.4 +7.2
Shanghai A 3,149.6 +7.5
Shanghai B 273.3 +0.9
PSE Comp 0.0
KOSPI 2,091.5 +11.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PLUS THERAPEUTICS INC PLUS THERAPEUTICS
Updated on 19 Sep 2019 (End of trading day)
Last (USD): 8.360 Change: +0.550 High: 9.490 Remarks: -
Change (%): +7.04 Low: 7.100
Open 7.850 Yesterday's Close 7.81
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 321,937 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -19.21347 Trailing EPS (USD) e -16.57433 NAV (USD) b -7.9746
PE a - Trailing PE f - Price / NAV b -1.0483
Dividend (USD) d - Cash In Hand (USD) g 5.8069 Issued & Paid-up Shares c 787,000
Dividend Yield (%) d - Price / Cash In Hand g 1.440 Treasury Shares h -
Beta - 75 Daysi -29.687 R-Squared - 75 Days(%)i 0.36 Market Cap (M) 6.579
Beta - 500 Daysi -31.063 R-Squared - 500 Days (%)i 0.32 Enterprise Value (M) 13.727
Piotroski F Score 3 Exchange Code PSTV Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 56.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PLUS THERAPEUTICS INC NASDAQ 6.579 - - -1.0483 -
Industry Biotechnology NASDAQ 2,218.858 126.679 97.660 5.1479 0.801
Local Peer AMGEN INC NASDAQ 117,331.501 13.978 14.744 10.8700 2.833
Local Peer GILEAD SCIENCES INC NASDAQ 83,535.042 15.313 14.028 3.6936 3.499
Local Peer CELGENE CORP NASDAQ 70,129.922 17.333 13.305 6.9774 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 45,274.145 21.596 20.440 8.9299 -
Local Peer ILLUMINA INC NASDAQ 44,864.400 54.315 47.830 10.3565 -
Local Peer BIOGEN INC NASDAQ 43,459.402 9.809 8.209 3.3552 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 31,446.268 12.865 15.197 3.2233 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,694.067 305.334 17.767 2.3313 -
Local Peer INCYTE CORPORATION NASDAQ 16,801.034 153.444 54.929 7.4765 -
Local Peer EXACT SCIENCES CORP NASDAQ 13,388.749 - - 17.4896 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,639.188 - - 4.6063 -
Local Peer SEATTLE GENETICS INC NASDAQ 12,289.849 - - 9.6632 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), UNIQURE N.V. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), OPKO HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), INTREXON CORP (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), OMEROS CORP (NASDAQ), NEXTCURE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), KURA ONCOLOGY INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), MACROGENICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), AVROBIO INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RETROPHIN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PERSONALIS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), DERMIRA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MERUS B V (NASDAQ), AGENUS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), XBIOTECH INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), RESTORBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), GERON CORP (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), RECRO PHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AFFIMED N V (NASDAQ), ATHERSYS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), KAMADA (NASDAQ), CUE BIOPHARMA INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), XOMA CORP (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), NOVAVAX INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CHIMERIX INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NANTKWEST INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), SAVARA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ADURO BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VACCINEX INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), SYNLOGIC INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), INFLARX N V (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INMUNE BIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), IVERIC BIO INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOCARDIA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ZAFGEN INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), HISTOGENICS CORP (NASDAQ), TOCAGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), TROVAGENE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), VAXART INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), OPGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ)
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 106,428.763 39.669 39.669 14.2225 1.132
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,160.167 76.456 22.537 5.0896 0.784
Global Peer SINO BIOPHARM HKEx 133,823.198 12.489 12.890 3.9315 0.688
Global Peer WUXI BIO HKEx 99,337.273 132.998 103.974 10.2256 -
Global Peer BEIGENE HKEx 61,754.851 - - 5.0870 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 32,661.585 196.417 - 9.2107 -
Global Peer 3SBIO HKEx 31,835.325 21.045 25.615 3.1378 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,685.780 42.835 - 2.7159 -
Other Global Peers FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), HAOHAI BIOTEC (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ASCLETIS-B (HKEx), CKLIFE SCIENCES (HKEx), ARCUS BIOSCIENCES INC (NYSE), NEXT SCIENCE LTD (ASX), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), KADMON HLDGS INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), DPHARMA (Bursa), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), BBI LIFE SCI (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), RESAPP HEALTH LIMITED (ASX), CEL-SCI CORP (NYSE American), PHYLOGICA LIMITED (ASX), PORT (SET), SYNTHETIC BIOLOGICS INC (NYSE American), IMMUTEP LTD (ASX), IMUGENE LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IBIO INC (NYSE American), CT ENTERPRISE (HKEx), ORTHOCELL LIMITED (ASX), REGENT PACIFIC (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), BIOSINO BIO-TEC (HKEx), BIOTRON (ASX), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), ISORAY INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ADALTA LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), BIONOMICS LTD (ASX), Suntar Eco-City^ (SGX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), NANOVIRICIDES INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), MGRC (Bursa), MEGASUN (Bursa), ACTINOGEN MEDICAL LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NOVITA HEALTHCARE LTD (ASX), CCP TECHNOLOGIES LTD (ASX), QT Vascular (SGX), TBG DIAGNOSTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.140
-12.00 %
10 Days --1.690
-16.82 %
20 Days -+0.060
+0.72 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.800 - 22.890 Change From 1 Year Low +4.560 % Change From 1 Year Low (%) +120.00
Change From 1 Year High -14.530 % Change From 1 Year High (%) -63.48
2 Years Range 3.800 - 22.890 Change From 2 Years Low +4.560 % Change From 2 Years Low (%) +120.00
Change From 2 Years High -14.530 % Change From 2 Years High (%) -63.48
5 Years Range 3.800 - 22.890 Change From 5 Years Low +4.560 % Change From 5 Years Low (%) +120.00
Change From 5 Years High -14.530 % Change From 5 Years High (%) -63.48
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development, and manufacturing scale up of complex and innovative treatments for patients battling cancer and other life-threatening diseases. The proprietary nanotechnology platform is currently centered around the enhanced delivery of a variety of drugs using novel liposomal encapsulation technology. Liposomal encapsulation has been extensively explored and undergone significant technical and commercial advances since it was first developed. The lead drug product candidate in pipeline, DocePLUS™, is being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, and other professionals. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.

Historical Price Data

Date Open High Low Close Volume VWAP
19 Sep 2019 7.850 9.490 7.100 8.360 321,937 -
18 Sep 2019 8.000 8.206 7.610 7.810 42,060 -
17 Sep 2019 9.130 9.260 7.750 7.950 188,638 -
16 Sep 2019 9.360 9.794 9.170 9.300 63,320 -
13 Sep 2019 9.450 10.080 9.110 9.500 87,326 -
12 Sep 2019 10.010 10.650 9.330 9.390 61,967 -
11 Sep 2019 9.810 10.970 9.810 10.200 56,967 -
10 Sep 2019 10.970 11.450 9.610 10.400 51,819 -
09 Sep 2019 9.830 10.800 9.120 10.780 94,571 -
06 Sep 2019 12.060 12.500 9.880 10.050 139,809 -
05 Sep 2019 15.550 15.680 11.000 11.810 275,763 -
04 Sep 2019 13.000 15.500 12.650 14.000 246,679 -
03 Sep 2019 14.560 15.880 13.360 13.360 205,968 -
30 Aug 2019 17.500 18.600 14.250 15.340 335,541 -
29 Aug 2019 22.000 22.890 15.680 16.810 612,932 -
28 Aug 2019 14.800 21.970 14.134 19.250 1,347,052 -
27 Aug 2019 12.390 16.490 10.750 14.950 716,509 -
26 Aug 2019 8.340 13.000 8.310 10.500 593,603 -
23 Aug 2019 8.000 8.700 7.730 8.300 175,556 -
22 Aug 2019 7.890 8.500 7.522 7.580 213,046 -
21 Aug 2019 6.870 10.350 6.550 7.300 1,505,925 -
20 Aug 2019 8.790 9.470 7.000 7.000 250,328 -
Summary
Current 2 Weeks
(06 Sep 2019 to 19 Sep 2019)
12.060 12.500 7.100 8.360 1,108,414 -
Previous 2 Weeks
(22 Aug 2019 to 05 Sep 2019)
7.890 12.500 7.100 11.810 4,722,649 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.